IFNA1 and melanoma: Benciet al. recently reported that prolonged IFN signalling in melanoma promotes epigenetic remodelling via transcriptional regulation of multiple T-cell inhibitory receptors, thus leading to resistance to anti-PD1 immunotherapy39.